Home
Accretion Pharmaceuticals Ltd ISIN Code

Accretion Pharmaceuticals Ltd
NSE: AccretionPha.
ISIN
Key Highlights
- The ISIN of Accretion Pharmaceuticals Ltd is INE0T8T01010 as of 22 May 09:14 AM .

Accretion Pharmaceuticals Ltd
NSE: AccretionPha.
Share Price
Market Price of Accretion Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 May 2025 | 82.95 |
ISIN Codes For Similar Companies
Company Name | |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceutical Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Asset Value vs Market Value of Accretion Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Accretion Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Accretion Pharmaceuticals Ltd
Historical Net Profit of Accretion Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Accretion Pharmaceuticals Ltd
Accretion Pharmaceuticals Ltd News Hub
NSE SME Accretion Pharmaceuticals' IPO ends with subscription of 7.31 times
The initial public offer (IPO) of Accretion Pharmaceuticals received bids for 2,00,06,400 shares as
Read more
19 May 25
NSE SME Accretion Pharma stumbles on market debut
The scrip was listed at 79, a discount of 21.78% over the initial public offer (IPO) price. The stoc
Read more
21 May 25